ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

Senate HELP Committee to Move Forward With Innovation Initiative
Facebook
Twitter
LinkedIn

Feb. 5, 2016

After nearly a year awaiting for a comprehensive draft of the Senate Innovation Initiative (the Senate’s separate but companion effort to the House-passed 21st Century Cures Act), Senate HELP Committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) late last month announced the committee would be moving its initiative forward by advancing individual pieces of legislation to be considered in three separate mark-ups this spring.

The first mark-up on Feb. 9 has been officially noticed and will consider the following pieces of legislation, all of which are considered “non-controversial” bills:

  • 2030, the Advancing Targeted Therapies for Rare Diseases Act of 2015
  • 1622, the FDA Device Accountability Act of 2015
  • 2014, the Next Generation Researchers Act
  • 800, the Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act
  • 849, the Advancing Research for Neurological Diseases Act of 2015
  • ____, the Preventing Superbugs and Protecting Patients Act
  • ____, the Improving Health Information Technology

Chairman Alexander and Ranking Member Murray also announced they intend to consider additional bills at two future markups, tentatively scheduled for March 9 and April 6.

CLSA is evaluating these proposals and intends to submit detailed feedback on the bills under consideration in advance of next week’s markup.  We will post our views on our website and share in the March Bulletin as well.

For questions, please contact Jenny Carey, CLSA’s Director of Federal Government Relations and Alliance Development (jcarey@califesciences.org).